Hepatitis

Infectious Viral hepatitis main Explanation of viral hepatitis Viral hepatitis is the most common type of hepatitis worldwide. citation Viral hepatitis is caused by five different viruses (hepatitis A, B, C, D, and E).

Hepatitis D main The hepatitis D virus causes chronic and fulminant hepatitis in the context of co-infection with the hepatitis B virus.

She said, “We estimate that about 18 million people are living with hepatitis in Nigeria, for hepatitis B we estimate for about 16 million and for hepatitis C about 2.2 million.

But one key difference between Hepatitis A and its viral cousins Hepatitis B and Hepatitis C is that it’s usually short-term and doesn’t become a long-lasting chronic condition.

Fulminant hepatitis Despite the relatively benign course of most viral cases of hepatitis, fulminant hepatitis represents a rare but feared complication.

Hepatitis A and hepatitis E behave similarly: they are both transmitted by the fecal-oral route, are more common in developing countries, and are self-limiting illnesses that do not lead to chronic hepatitis.

Hepatitis E main Similar to Hepatitis A, hepatitis E manifests as large outbreaks and epidemics associated with fecal contamination of water sources.

Montgomery has long advocated transplanting these organs in non-hepatitis C infected individuals because new medications to treat hepatitis C have a cure rate of more than 95%.

Of the 5 types of hepatitis infections, hepatitis B and C cause most of the disease and deaths.

World Hepatitis Day aims to eliminate hepatitis as a public health threat by 2030.

According to the World Health Organization’s 2024 Global Hepatitis Report, only 36% of people infected with hepatitis C globally are diagnosed and 20% receive curative treatment.

Hepatitis B reactivation, including life threatening hepatitis B, was observed in the clinical program.

She was speaking during a programme organised ahead of World Hepatitis Day observed by Chief Medical Officer Dimapur along with National Viral Hepatitis Control Programme (NVHCP) and ARK Foundation under the theme 'It’s time for Action' today.

The head of the Hepatitis Clinic at Juba Teaching Hospital noted that the majority of reported Hepatitis cases at the facility are diagnosed at advanced stages, often resulting in fatalities.

The portal is designed to offer comprehensive protection against Hepatitis B, a virus known for causing severe complications such as chronic hepatitis, cirrhosis, and liver cancer.

Hepatitis A and hepatitis B. These aren’t age-related; the vaccines are recommended for people with certain health conditions, including chronic liver disease and H.I.V. infection, or for travelers to countries where the diseases are widespread.

Strong progress has been made in hepatitis prevention, but coverage of timely hepatitis B birth dose is only 10%.

The benefits were seen regardless of sex, the severity of hepatitis, or type of hepatitis virus (B or C).

The company has previously been involved in developing vaccines for hepatitis A, hepatitis B and H1N1 influenza.

The momentum towards viral hepatitis elimination in sub-Saharan Africa will need a new and highly focused approach to ensure that early gains in the coverage of core viral hepatitis interventions are not lost.